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1Background and Purpose- As there is sexual dimorphism in the regulation of vascular tone,1
the aim of this present study was to determine whether there are sex differences in2
perivascular adipose tissue (PVAT) - mediated regulation of the porcine coronary artery3
(PCA) tone.4
Experimental Approach- Isometric tension recording system was used to record changes in5
tone in PCAs. Western blot analysis was performed to examine the expression of adiponectin6
in PVAT and adiponectin receptors (adipo 1 receptor and adipo 2 receptor) and adiponectin7
binding protein (APPL1) in PCA. The level of adiponectin released from PVAT was8
measured using ELISA.9
Key Results- In the presence of adherent PVAT, contractions to the thromboxane mimetic10
U46619 and endothelin-1 were significantly reduced in PCAs from females, but not males. In11
PCAs pre-contracted with U46619, re-addition of PVAT caused relaxation in PCAs from12
females, but not males. This relaxant response in females was attenuated by combined13
inhibition of NO synthase (with L-NAME) and cyclooxygenase (with indomethacin). Pre-14
incubation with an anti-adiponectin antibody abolished the relaxant effects of PVAT. The15
adiponectin receptor agonist (adipoRon) produced a greater relaxation in PCAs from females16
compared to males. However, there was no difference in either expression or release of17
adiponectin from PVAT between sexes. Similarly, there was no difference in expression of18
adiponectin receptors or the adiponectin receptor adaptor protein APPL1 in PCAs.19
Conclusion and Implications- These findings demonstrate a clear sex difference in the20
regulation of coronary artery tone in response to adiponectin receptor stimulation, which may21
underlie the anticontractile effects of PVAT in females.22
Abbreviations23
Adiponectin receptor (adipo receptor), adaptor protein, phosphotyrosine interacting with PH24
domain and leucine zipper 1 (APPL1), cyclooxygenase (COX), endothelin-1 (ET-1), NG-25
nitro-L-arginine methyl ester (L-NAME), myosin light chain (MLC), nitric oxide (NO), nitric26
oxide synthase (NOS), perivascular adipose tissue (PVAT), porcine coronary artery (PCA),27
9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin F2α (U46619). 28 
29
2Introduction1
Adipose tissue has traditionally been described as being simply a structural support, with2
additional lipid storage (white adipose tissue) and thermoregulator (brown adipose tissue)3
roles (Cannon & Nedergaard, 2004; Mariman & Wang, 2010). However, compelling4
evidence in recent years has led to the view that adipose tissue is in fact an active secretory5
organ which releases several bioactive signalling molecules, collectively termed adipokines,6
which are important in both health and disease (Fortuno et al., 2003; Havel, 2004; Thalmann7
& Meier, 2007; Yamawaki et al., 2010). Multiple studies have established that there are8
variations in the function of adipose tissue in different sexes where, for instance, women have9
higher circulating adiponectin levels compared to men (Arita et al., 2012; Cnop et al., 2003;10
Nishizawa et al., 2002).11
Perivascular adipose tissue (PVAT) is positioned around the blood vessel and is regarded as12
being distinct from the adventitia. The recent interest in perivascular adipose tissue as an13
endocrine and paracrine organ has led to a number of studies investigating the characteristics14
of various fat depots in the body. Soltis and Cassis (1991) firstly described that perivascular15
adipose tissue significantly attenuated vascular responsiveness of Sprague-Dawley rat aortae16
to noradrenaline (Soltis & Cassis, 1991). This result was confirmed by Löhn et al. (2002)17
who re-examined the idea of periadventitial vasoregulation. Their study provided additional18
proof that PVAT-inhibited vasoconstriction induced by a number of additional agonists such19
as angiotensin II, serotonin and phenylephrine (Lohn et al., 2002). Adiponectin is a major20
factor secreted by adipocytes (Scherer et al., 1995) and exerts its action by binding to its21
receptors (adipo 1 receptor and adipo 2 receptor) (Kadowaki & Yamauchi, 2005). Although22
downstream regulation of signalling of these receptors is yet to be fully identified,23
overexpression of APPL1 (adaptor protein, phosphotyrosine interacting with PH domain and24
leucine zipper 1) enhances, and suppression of APPL1 level attenuates, adiponectin25
signalling and its downstream events (Mao et al., 2006).26
Functional studies have found that adiponectin can relax murine mesenteric artery by opening27
Kv channels (Fesus et al., 2007), and (Greenstein et al., 2009) concluded that adiponectin28
was the anti-contractile adipokine released from rat mesenteric arterial PVAT. Moreover, a29
fragment of the adiponectin receptor abolished the PVAT-induced vasorelaxation in human30
small arteries taken from subcutaneous gluteal fat biopsy samples, which further suggests that31
adiponectin is a predominant mediator of the relaxation (Greenstein et al., 2009).32
Noteworthy, there are accumulating data about the potential effect of PVAT in regulating the33
3vascular tone where PVAT could induce both vasorelaxation and vasoconstriction depending1
on the anatomical position, species and condition (Nava & Llorens, 2016; Owen et al., 2013;2
Szasz et al., 2013; Verlohren et al., 2004; Yudkin et al., 2005).3
In recent studies we have demonstrated that there are sex differences in the regulation of tone4
in the porcine coronary artery (Wong et al., 2014). As there are also sex differences in the5
release of adipokines from adipose tissue in general, in this study we investigated whether6
there are sex differences in the regulation of vascular tone by PVAT in the porcine coronary7
artery. Our findings demonstrate that PVAT surrounding coronary arteries from females has8
an anti-contractile effect, which is not seen in males, indicating that PVAT may have a9
protective effect on coronary arteries in females, but not males.10
11
4Methods1
Tissue preparation2
Hearts from male and female pigs (large white hybrid pigs, 4-6 months old, weighing ~ 50kg)3
were obtained from a local abattoir and transported back to the laboratory in ice-cold4
modified Krebs’-Henseleit solution (118 mM NaCl, 4.8 mM KCl, 1.1 mM MgSO4, 25 mM5
NaHCO3, 1.2 mM KH2PO4, 12 mM D-glucose, 1.25 mM CaCl2). Experiments were blinded6
as the experimenter did not know whether the tissues were from male or female animals until7
after the experiments had been undertaken. The anterior proximal part of the coronary artery8
was then dissected and placed in Krebs’-Henseleit solution pre-gassed with 5% CO2 and 95%9
O2 and kept overnight in the refrigerator. On the second day, fine dissection was performed to10
prepare paired PCAs rings from each artery ensuring vessels were not stretched or damaged.11
PCAs were then cut into rings of approximately 5mm in length and suspended in a12
multichannel 5 ml organ bath. Each bath was filled with 5 ml of Krebs’-Henseleit solution13
and maintained at 37oC and constantly gassed with carbogen (95% O2, 5% CO2). Tension14
was measured and recorded using a Powerlab data acquisition system (ADInstruments) via an15
amplifier.16
Experimental protocol17
Organ bath studies18
Tissues were initially pre-tensioned to 73.6mN, determined from preliminary studies, and19
then left to equilibrate for approximately 30-45 minutes. Once a stable baseline was reached,20
two consecutive responses to 60mM KCl were obtained for standardization. After about 2021
min the KCl was washed out with fresh Krebs’-Henseleit solution. Following the return to a22
stable baseline and, after a further 15-30 minutes, exposure to KCl was repeated. Once again,23
the tissue was washed out with Krebs’-Henseleit solution, to allow the segment tone to re-24
stabilize to baseline. The data were calculated and expressed as a percentage of the25
contraction in response to 60 mM KCl. The KCl response is considered as a reference to the26
viability and activity of each segment in order to avoid the individual variation in the27
response of the coronary artery. Thereafter relevant test compounds were added and allowed28
60 minutes incubation time. The following test compounds were used: L-NAME (300 µM) to29
inhibit NO synthase (Wong et al., 2014), and indomethacin (10 µM) (Malinowski et al.,30
2008) to inhibit cyclooxygenase. Pre-incubation with an anti-adiponectin antibody (1:100;31
ABIN1857924, antibodies-online Inc., Atlanta, USA) was performed to determine the role of32
5adiponectin in PVAT-induced vasorelaxation in females. U46619 (9,11-Dideoxy-11α,9α-1 
epoxymethano-prostaglandin F2α)  was added cumulatively (1 nM-300 nM) to induce 2 
contraction in the arterial rings, which was calculated as a percentage of the contraction in3
response to 60 mM KCl. In some experiments endothelin-1 (ET-1) (1 nM-300 nM) was used4
as contractile agent. In other sets of experiments, PVAT (0.3 g) was added to vessels in5
which the PVAT had previously been removed and pre-contracted with U46619 to a level of6
40-60% of the maximum KCl response. In a further set of experiments, cumulative7
concentration response curves to the adiponectin receptor agonist, adipoRon (1-100 µM)8
(Okada-Iwabu et al., 2013) were performed in PCAs pre-contracted with U46619.9
Western immunoblotting10
Polyacrylamide gel electrophoresis followed by Western immunoblotting was performed to11
determine the expression of adiponectin levels in PVAT, and the adiponectin receptors (adipo12
1 receptor and adipo 2 receptor) and APPL1 in PCAs from different pigs from each sex.13
PVAT or PCA samples were finely dissected and homogenized on ice using Tris-EDTA14
buffer (pH 7.4) and protease inhibitor cocktail (Calbiochem, VWR International Ltd,15
Lutterworth, Leicestershire, UK). After estimation of the protein content of each sample16
using a Lowry protein assay, Laemmli solubilisation buffer was added. Samples were then17
heated at 100oC for 5 min and centrifuged at 13,000×g for 1 min.  PVAT (20 μg) and PCA 18 
(20 μg) samples were separated using a 4–20% gradient polyacrylamide gradient gel (Bio-19 
Rad, Hemel Hempstead, Hertfordshire, UK) and then transferred onto nitrocellulose20
membrane (GE Healthcare, Little Chalfont, Buckinghamshire, UK) by Western blotting.21
Porcine skeletal muscle and rat liver tissues were used as a positive control for adipo 122
receptor and adipo 2 receptor , respectively (Ding et al., 2009). Membranes were then23
blocked with 5% w/v non-fat milk, or 5% w/v BSA in the case of APPL1, in Tris-buffered24
saline containing 0.1% Tween 20 (TBST) at room temperature for 1 h. The blot was then25
incubated with rabbit anti-adiponectin antibody (1:400 dilution; ABIN1857924, antibodies-26
online Inc., Atlanta, USA), rabbit anti-adipo 1 receptor antibody (1:500; 250476, Abbiotec,27
USA), rabbit anti-adipo 2 receptor antibody (1:250 dilution; orb10047, Biorbyt, Cambridge,28
UK) and rabbit anti-APPL1 antibody (1:2000; mAb 3858, Cell Signaling Technology, UK) in29
5% milk, or in 5% BSA in the case of APPL1 antibody, in Tris-buffer overnight at 4°C.30
Membranes were also incubated with a mouse anti-β-actin antibody (1:50,000 in 5% milk; 31 
Sigma-Aldrich, Poole, Dorset, UK) or an anti-mouse myosin light chains (MLC) antibody32
6(1:1000 in 5% milk; Sigma-Aldrich, Poole, Dorset, UK) as a loading control as well as to1
quantify porcine proteins. On the second day, the blot was washed in TBST followed by2
incubation with IRDye 800CW goat anti-rabbit and IRDye 680CW goat anti-mouse3
secondary antibodies (both 1:10,000 dilution; IRDye, Licor, Cambridge, UK). The4
immunoblot was then visualized using an Odyssey system from Licor and intensity of the5
bands measured using Odyssey Image Studio (Licor).6
7
Determination of adiponectin levels released from PVAT8
PVAT (0.15g) was incubated in 1ml of Krebs’-Henseleit solution at 37oC. Adiponectin levels9
in the buffer were then determined using a pig adiponectin ELISA Kit (abx255420; Abbexa,10
Cambridge, UK) following the manufacturer’s protocol. The range of standard curve is 31.2511
ng/ml - 1000 ng/ml, sensitivity: < 18.75 ng/ml. The intra-assay coefficient of variation was12
10.1.13
14
Data and statistical analysis15
Data are expressed as mean ± S.E.M. where n = the number of different animals. The16
concentration-response curves were fitted to a sigmoidal curve with a variable slope using17
four parameters logistic equation using GraphPad Prism software. The maximum percentage18
contraction (Rmax) and the negative log of concentration required to produce half the maximal19
contraction of the induced tone (pEC50) were calculated from the fitted curves. Rmax and20
pEC50 values were analysed using a 2-tailed, paired or unpaired Student’s t-test to compare21
differences between 2 groups, as appropriate. Differences between 3 or more groups were22
assessed using a one-way ANOVA or two-way ANOVA in conjunction with the Sidak’s23
post-hoc test to assess possible difference at individual concentrations. P <0.05 was24
considered statistically significant. Statistical analysis was performed by GraphPad Prism25
(Version 6). The data and statistical analysis comply with the recommendations on26
experimental design and analysis in pharmacology (Curtis et al., 2015).27
Materials28
All drugs were purchased from Sigma-Aldrich except for endothelin-1 which came from29
Tocris Bioscience and adiponectin from Antibodies-online Inc. Stock solutions of L-NAME,30
and adiponectin were dissolved in distilled water. Stock solution of indomethacin was31
7dissolved in absolute ethanol. Stock solutions of U46619 were made to 10mM in ethanol1
whilst DMSO was used as a solvent to make 10mM of adipoRon. All further dilutions of the2
stock solutions were made using distilled water. All stocks were kept frozen at -20oC.3
4
8Results1
The effects of PVAT on U46619-induced vasoconstriction in PCAs from female2
and male pigs.3
In order to determine the effects of perivascular fat on vascular contraction, concentration-4
response curves to the thromboxane mimetic U46619 were determined in coronary artery5
segments from female and male pigs (Figure 1 A and B), with and without adherent PVAT.6
The presence of fat reduced the maximum contraction to U46619 in coronary arteries from7
females. There was also a rightward shift in the concentration-response curve. On the other8
hand, the presence of PVAT had no effect on the U46619 induced-contraction in coronary9
arteries from male pigs (Figure 1B). Similarly, the endothelin-1-induced vasoconstriction10
was significantly reduced in coronary arteries from female pigs in the presence of fat with no11
change in pEC50 (Figure 1C). Furthermore, PVAT had no effect on the endothelin-1-mediated12
vasoconstriction in PCAs from male (Figure 1D). There was no significant difference in the13
size of the contractile response to 60 mM KCl with PVAT compared to without PVAT14
(females, control = 8 ± 0.8 g without PVAT compared to 6.4 ± 0.6 g with PVAT; males,15
control =9.4 ± 1.2 without PVAT compared to 7.7 ± 0.9 g with PVAT)16
Acute effects of added PVAT on rings pre-contracted with U46619.17
Coronary arterial segments from female pigs with fat removed were pre-contracted18
submaximally with U46619. Once a stable tone was obtained, 0.3 g PVAT was then added19
(see Figure 2C). PVAT from female animals caused immediate relaxation (R) (Figure 2 A20
and C). On the other hand, PVAT from male animals had no significant effect on the21
U46619-induced vasoconstriction compared to time control (Figure 2B). Furthermore, a22
crossover study in which PVAT from females was added to PCAs from males showed no23
vasorelaxant effect (Figure 2D).24
The effects of L-NAME and indomethacin on the anti-contractile effect of PVAT25
in PCAs.26
The maximum response of PCAs to U46619 was significantly inhibited in the presence of27
PVAT, as before (Figure 3). A combination of L-NAME and indomethacin had no effect on28
the concentration-response curve to U46619 in the absence of PVAT, but this combination29
prevented the inhibitory effect of PVAT on the U46619 response (Figure 3A and B). On the30
9other hand, incubation with either L-NAME or indomethacin alone had no effect on the anti-1
contractile response of PVAT (Figure 3B).2
Role of adiponectin in PVAT-mediated vasorelaxation in females3
Previous studies have indicated that adiponectin acts through nitric oxide synthase (NOS) and4
cyclooxygenase-dependent ways. Therefore we determined the role of adiponectin in the5
relaxation effect seen in the presence of PVAT. Segments of coronary arteries from females6
were pre-treated with an anti-adiponectin antibody, in order to bind any released adiponectin.7
In the presence of the anti-adiponectin antibody, the PVAT-induced relaxation was abolished8
(Figure 4).9
Adiponectin expression in PVAT10
Our data indicate that PVAT from females, but not males, causes relaxation of coronary11
arteries through the release of adiponectin. In order to determine whether the differences in12
the role of PVAT in arteries from male and female animals was due to differences in the13
amount of adiponectin in PVAT, the expression of adiponectin in PVAT was determined by14
Western immunoblotting. There was no significant difference in the expression of15
adiponectin in coronary artery PVAT from female and male animals (Figure 5A,B).16
Adiponectin release from PVAT17
As there was no difference in the level of expression of adiponectin in PVAT between male18
and female animals, we determined whether there is a difference in the release of adiponectin19
from PVAT. Although adiponectin could be detected in the buffer that the PVAT was20
incubated in, there was no significant difference in the level of released adiponectin between21
PVAT from male and female animals (Figure 5C).22
Responsiveness of porcine coronary arteries to adipoRon23
As there was no difference in either the expression of adiponectin or release of adiponectin24
from PVAT, we determined whether there was a difference in the sensitivity to adiponectin25
receptor activation between male and female animals. AdipoRon, an adiponectin receptor26
agonist, produced a concentration-dependent relaxation of coronary arteries from both female27
and male pigs. However, there was a greater relaxation in arteries from female pigs compared28
to male (at 100 µM, females: 106±8 % relaxation, n=6; males: 78±6 % relaxation, n=8).29
10
AdipoRon also appeared to be more potent in arteries from females compared to males, based1
on the observation that adipoRon produced a relaxation at lower concentrations (Figure 6).2
Expression of Adiponectin receptors in PCAs3
To clarify the difference in the responsiveness of PCAs in different sexes, we measured the4
level of expression of two different isoforms of adiponectin receptors (adipo 1 receptor and5
adipo 2 receptor) in PCAs from both sexes, using Western immunoblotting. Numerous bands6
were detected with the anti-adipo 1 receptor antibody, but none lined up with the band in the7
rat skeletal muscle positive control at the predicted molecular weight of 40 kDa, suggesting8
there is no detectable expression of adipo 1 receptor in PCAs from either females or males9
(Figure 7A). Similarly numerous bands were obtained with the anti-adipo 2 receptor antibody10
(Figure 7B). A band at the predicted molecular weight of 42 kDa lined up with a band at the11
same molecular weight in the rat liver positive control was taken to be adipo 2 receptor. This12
band was expressed in PCAs from both sexes. However, there was no apparent difference in13
the expression of adipo 2 receptor in PCAs from females compared to males (Figure 7B,C).14
Expression of APPL1 in PCAs15
As there was no difference in the expression of adiponectin receptors between females and16
males PCAs, we then investigated the expression of the adiponectin binding protein APPL117
in PCAs by Western immunoblotting. A band for APPL1 was detected at the predicted18
molecular weight of 82 kDa. However, there was no significant difference in APPL119
expression between PCAs from both sexes (Figure 7D,E).20
11
Discussion1
The recognition that perivascular adipose tissue is not simply a reservoir for lipid storage, but2
is also a complex endocrine organ has led to substantial research efforts to establish the3
mechanistic links between the PVAT and vascular tone regulation. The majority of research4
in this area has been carried out on blood vessels from male animals and has concentrated5
mostly on murine aorta and mesenteric vessels. A few studies have determined the role of6
PVAT in the regulation of coronary artery tone, but this is the first study to compare the7
effects of PVAT from male and female animals. We have identified clear sex differences in8
the regulation of coronary artery tone by PVAT, with PVAT from female animals producing9
an anti-contractile, relaxation response, which was not seen in PVAT from male animals.10
In the presence of fat, contractile responses to both the thromboxane receptor agonist U4661911
and ET-1 were reduced in coronary arteries from female pigs, but not from male pigs,12
indicating the release of an anti-contractile compound from the PVAT surrounding the13
coronary arteries in females. Re-addition of fat removed from the coronary arteries into the14
tissue baths produced a relaxation response in arteries from females, but not males. In order15
to confirm this finding, we performed a crossover study in which PVAT from females was16
added to male arteries. Although PVAT from females induced a relaxation in coronary artery17
from females, the PVAT from females did not produce a relaxation in coronary arteries from18
males. Taken together, these data suggest that the PVAT surrounding coronary arteries from19
female animals may have a protective, anti-contractile role, which may contribute to the20
reduced incidence of coronary artery disease in females.21
The present results are consistent with the studies by (Gao et al., 2007) and (Malinowski et22
al., 2008) which have shown that PVAT reduces vascular tone in the rat aorta and human23
internal thoracic arteries, respectively, although sex differences in these responses were not24
determined. In contrast, previous studies in porcine coronary artery have indicated the release25
of a contractile agent from PVAT, although again sex differences in the responses were not26
examined (Owen et al., 2013).27
In mouse mesenteric arteries, the anti-contractile effect of PVAT is mediated through either28
NO or COX-dependent pathways (Lynch et al., 2013). Similarly, in this study, we29
demonstrated that the anti-contractile effect of PVAT in coronary arteries from female pigs30
was sensitive to inhibition with a combination of the nitric oxide synthase inhibitor L-NAME31
and the cyclooxygenase inhibitor indomethacin, whereas inhibition of each enzyme32
separately had no significant effect. These data indicate the involvement of both NO and33
12
COX metabolites in the PVAT response. This is similar to the findings of (Lynch et al.,1
2013) who also found that inhibition of both NOS and COX was required to inhibit the anti-2
contractile response. Dual inhibition is probably necessary because of compensatory3
activation of the other pathway. In general, this observation is in line with a previous study on4
aorta from Wistar rats which found that PVAT could exert its anti-contractile effects by5
secreting a relaxant factor which mediates endothelium-dependent vasorelaxation through6
NO release (Gao et al., 2007). On the other hand, these findings differ from a previous study7
by (Malinowski et al., 2008) which was conducted on the human internal thoracic artery8
where they reported that blocking NOS and COX could not restore the vascular response in9
intact rings. In fact, these differences may reflect changes in vascular responses in10
cardiovascular disease as the human vessels used were from patients with severe coronary11
artery disease and therefore likely to have endothelial dysfunction. In addition, the12
inconsistency of findings for the role of NO and COX in all previous studies could probably13
be due to the indefinite sex used.14
In order to identify the mechanism underlying the sex difference in the anti-contractile effect15
of PVAT in the porcine coronary artery, we investigated the role of adiponectin. Adiponectin16
is the most abundant adipokine in the circulation and has been shown to activate both NO and17
COX-dependent pathways (Lee et al., 2010; Shibata et al., 2005; Tan et al., 2004). As there18
is no selective adiponectin receptor antagonist available, we used an anti-adiponectin19
antibody to bind any adiponectin released from the PVAT and prevent it from activating the20
receptor on the artery. To this end, we determined the effect of the antibody on the relaxation21
due to addition of PVAT, rather than using fat-attached arteries. This is because the close22
proximity of the fat to the blood vessel in fat-attached preparations may not allow the23
antibody access to bind released adiponectin. Under these conditions, the presence of the24
anti-adiponectin antibody completely prevented the PVAT-induced relaxation, indicating that25
adiponectin is likely to be the mediator released from the fat. Therefore, we investigated26
whether the sex differences in the relaxation were due to differences in adiponectin27
expression, release or function. Using Western immunoblotting we identified the presence of28
adiponectin in PVAT from the coronary artery, although there was no difference between29
male and females. Furthermore, there was no difference in the level of adiponectin released30
from PVAT, indicating that the difference in the relaxation response is not due to a difference31
in either expression or release of adiponectin. On the other hand, using an adiponectin32
receptor agonist, adipoRon, we demonstrated that activation of the adiponectin receptor33
13
produces a greater relaxation and at lower concentrations in coronary arteries from females1
compared to males. These data indicate that the sex difference in the anti-contractile effect of2
PVAT is likely to be due to a difference in the responsiveness of the arteries to adiponectin.3
Noteworthy, responses to adiponectin receptor activation are independent of the endothelium4
in that denudation of the endothelium did not alter the relaxation to adipoRon in the coronary5
artery (Supplementary figure 1).6
In an attempt to identify the reason for the differences in adiponectin response, we7
determined the expression of the adiponectin receptors in the coronary artery. Using Western8
immunoblotting, we identified expression of adipo 2 receptor but not adipo 1 receptor in9
PCAs from both sexes. However, there was no apparent difference in the expression of adipo10
2 receptor between males and females.11
Since no sex difference was identified in adiponectin receptors expression, so we investigated12
the expression of APPL1 which has been identified as an adipo 1 receptor and adipo 213
receptor binding protein (Buechler et al., 2010) and considered as a downstream regulator of14
adiponectin signalling (Cheng et al., 2007; Mao et al., 2006). Although we have showed an15
expression of this adaptor protein APPL1 in PCAs, there was no significant difference16
between sexes. The limitation in our investigation is that the expression of different proteins17
studied in this research were examined in total homogenate rather than vascular smooth18
muscle only. In addition, total adiponectin receptors expression were measured rather than19
the expression of just surface receptors. As adiponectin receptors are distributed in the20
cytoplasm (Ding et al., 2009) and on the cell membrane (Yamauchi et al., 2003), differences21
in either cellular or subcellular distribution could underlie the sex differences.22
We have previously demonstrated sex differences in intracellular signalling pathways23
involved in vasorelaxation. In particular, there are sex differences in the relative contribution24
of the NO and EDH signalling pathways in the porcine coronary artery, as well as differences25
in the mechanisms underlying the EDH response (Wong et al., 2015a; Wong et al., 2015b).26
Therefore, differences in signalling may contribute to the sex differences in adiponectin27
relaxation seen in this study. In addition, malfunction and resistance to adiponectin have been28
identified in different conditions such as obesity (Bruce et al., 2005; Chen et al., 2005), high29
fat diet (Mullen et al., 2009) and cardiovascular diseases (Lau et al., 2011). Therefore, we30
cannot exclude the possibility of adiponectin resistance in the coronary arteries from males.31
Although there was reduced relaxation to AdipoRon in porcine coronary arteries from males,32
there was still a relaxation and not the complete absence of relaxation seen with the addition33
14
of PVAT. The lack of relaxation to PVAT in males could be because the amount of1
adiponectin released from PVAT is too small to induce a relaxation in males. Alternatively,2
other studies have indicated that an unknown contractile factor is released from porcine3
coronary artery PVAT. This may counteract the relaxation response to adiponectin in males.4
5
Clinical relevance of the study6
It is becoming increasingly clear that PVAT plays a role in cardiovascular7
pathophysiology. For instance, an apparent link has been found between an increase in PVAT8
and coronary artery disease (Verhagen & Visseren, 2011). In addition, several clinical studies9
have demonstrated vascular protective effects of adiponectin as low plasma levels of10
adiponectin is associated with hypertension and other cardiovascular diseases (Aprahamian &11
Sam, 2011; Imatoh et al., 2008; Kim et al., 2013) and high levels of adiponectin are12
associated with a reduced incidence of acute coronary syndrome and acute myocardial13
infarction (Mittal et al., 2013; Pischon et al., 2004). The present study demonstrates that only14
PVAT from females has an anti-contractile effect on the coronary artery tone and thus may15
contribute to the reduced incidence of cardiovascular disease in pre-menopausal women.16
However, further studies are required to determine whether similar sex differences in the17
regulation of tone by PVAT are observed in other blood vessels, and, importantly, whether18
similar effects are seen in humans.19
In summary, the present study illustrates that there are clear sex differences in PVAT20
function, where PVAT exhibits an anti-contractile responses in PCAs from female pigs, but21
not male pigs, which appears to be due to increased adiponectin activity. The sex difference22
in the PVAT response is not explained by a difference in the expression or release of23
adiponectin, but may be explained by a greater sensitivity of coronary arteries from females24
to adiponectin receptor activation. This is the first study to demonstrate that PVAT may have25
a protective effect on coronary arteries in females, which is not present in males. This26
protective effect could contribute to the cardiovascular protective effects observed in females.27
Future studies into the role of PVAT on vascular tone should take into account potential sex28
differences in the responses.29
30
15
Acknowledgements1
We thank G. Woods & son Ltd, Clipstone, Nottinghamshire, UK for the supply of pig hearts.2
This work was supported by the Iraqi ministry of higher education and scientific research.3
Conflicts of interest4
None.5
6
16
References1
Aprahamian TR, & Sam F (2011). Adiponectin in cardiovascular inflammation and obesity.2
Int J Inflam 2011: 376909.3
4
Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. (2012). Paradoxical5
decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem Biophys Res6
Commun 425: 560-564.7
8
Bruce CR, Mertz VA, Heigenhauser GJ, & Dyck DJ (2005). The stimulatory effect of9
globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is10
impaired in skeletal muscle from obese subjects. Diabetes 54: 3154-3160.11
12
Buechler C, Wanninger J, & Neumeier M (2010). Adiponectin receptor binding proteins--13
recent advances in elucidating adiponectin signalling pathways. FEBS Lett 584: 4280-4286.14
15
Cannon B, & Nedergaard J (2004). Brown adipose tissue: function and physiological16
significance. Physiological reviews 84: 277-359.17
18
Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O'Brien P E, Dixon JB, et al. (2005).19
Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in20
cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90: 3665-21
3672.22
23
Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, et al. (2007). Adiponectin-24
induced endothelial nitric oxide synthase activation and nitric oxide production are mediated25
by APPL1 in endothelial cells. Diabetes 56: 1387-1394.26
27
Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. (2003).28
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma29
lipoproteins: evidence for independent roles of age and sex. Diabetologia 46: 459-469.30
31
Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA, et al. (2015).32
Experimental design and analysis and their reporting: new guidance for publication in BJP.33
Br J Pharmacol 172: 3461-3471.34
35
Ding Q, Wang Z, & Chen Y (2009). Endocytosis of adiponectin receptor 1 through a clathrin-36
and Rab5-dependent pathway. Cell Res 19: 317-327.37
38
Fesus G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC, et al. (2007). Adiponectin39
is a novel humoral vasodilator. Cardiovascular research 75: 719-727.40
41
Fortuno A, Rodriguez A, Gomez-Ambrosi J, Fruhbeck G, & Diez J (2003). Adipose tissue as42
an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular43
diseases. Journal of physiology and biochemistry 59: 51-60.44
45
Gao YJ, Lu C, Su LY, Sharma AM, & Lee RM (2007). Modulation of vascular function by46
perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol47
151: 323-331.48
49
17
Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. (2009).1
Local inflammation and hypoxia abolish the protective anticontractile properties of2
perivascular fat in obese patients. Circulation 119: 1661-1670.3
4
Havel PJ (2004). Update on adipocyte hormones: regulation of energy balance and5
carbohydrate/lipid metabolism. Diabetes 53 Suppl 1: S143-151.6
7
Imatoh T, Miyazaki M, Momose Y, Tanihara S, & Une H (2008). Adiponectin levels8
associated with the development of hypertension: a prospective study. Hypertens Res 31:9
229-233.10
11
Kadowaki T, & Yamauchi T (2005). Adiponectin and adiponectin receptors. Endocr Rev 26:12
439-451.13
14
Kim DH, Kim C, Ding EL, Townsend MK, & Lipsitz LA (2013). Adiponectin levels and the15
risk of hypertension: a systematic review and meta-analysis. Hypertension 62: 27-32.16
17
Lau WB, Tao L, Wang Y, Li R, & Ma XL (2011). Systemic adiponectin malfunction as a risk18
factor for cardiovascular disease. Antioxid Redox Signal 15: 1863-1873.19
20
Lee FP, Jen CY, Chang CC, Chou Y, Lin H, Chou CM, et al. (2010). Mechanisms of21
adiponectin-mediated COX-2 induction and protection against iron injury in mouse22
hepatocytes. J Cell Physiol 224: 837-847.23
24
Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, & Sharma AM (2002).25
Periadventitial fat releases a vascular relaxing factor. FASEB J 16: 1057-1063.26
27
Lynch FM, Withers SB, Yao Z, Werner ME, Edwards G, Weston AH, et al. (2013).28
Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce29
anticontractile responses. Am J Physiol Heart Circ Physiol 304: H786-795.30
31
Malinowski M, Deja MA, Golba KS, Roleder T, Biernat J, & Wos S (2008). Perivascular32
tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent33
anticontractile factor. European journal of cardio-thoracic surgery : official journal of the34
European Association for Cardio-thoracic Surgery 33: 225-231.35
36
Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, et al. (2006). APPL1 binds to37
adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8: 516-38
523.39
40
Mariman EC, & Wang P (2010). Adipocyte extracellular matrix composition, dynamics and41
role in obesity. Cellular and molecular life sciences : CMLS 67: 1277-1292.42
43
Mittal A, Gupta MD, Meennahalli Palleda G, Vyas A, & Tyagi S (2013). Relationship of44
plasma adiponectin levels with acute coronary syndromes and coronary lesion severity in45
north Indian population. ISRN Cardiol 2013: 854815.46
47
Mullen KL, Pritchard J, Ritchie I, Snook LA, Chabowski A, Bonen A, et al. (2009).48
Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin49
resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 296: R243-251.50
18
1
Nava E, & Llorens S (2016). The paracrine control of vascular motion. A historical2
perspective. Pharmacol Res 113: 125-145.3
4
Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. (2002).5
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.6
Diabetes 51: 2734-2741.7
8
Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami K, Matsuda K, et al. (2013).9
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503:10
493-499.11
12
Owen MK, Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP, et al. (2013).13
Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle:14
influence of obesity. Circulation 128: 9-18.15
16
Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, & Rimm EB (2004). Plasma17
adiponectin levels and risk of myocardial infarction in men. JAMA 291: 1730-1737.18
19
Scherer PE, Williams S, Fogliano M, Baldini G, & Lodish HF (1995). A novel serum protein20
similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749.21
22
Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al. (2005). Adiponectin23
protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-24
dependent mechanisms. Nat Med 11: 1096-1103.25
26
Soltis EE, & Cassis LA (1991). Influence of perivascular adipose tissue on rat aortic smooth27
muscle responsiveness. Clinical and experimental hypertension Part A, Theory and practice28
13: 277-296.29
30
Szasz T, Bomfim GF, & Webb RC (2013). The influence of perivascular adipose tissue on31
vascular homeostasis. Vasc Health Risk Manag 9: 105-116.32
33
Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, et al. (2004). Hypoadiponectinemia is34
associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89:35
765-769.36
37
Thalmann S, & Meier CA (2007). Local adipose tissue depots as cardiovascular risk factors.38
Cardiovascular research 75: 690-701.39
40
Verhagen SN, & Visseren FL (2011). Perivascular adipose tissue as a cause of41
atherosclerosis. Atherosclerosis 214: 3-10.42
43
Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, et al. (2004). Visceral44
periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 44:45
271-276.46
47
Wong PS, Randall MD, & Roberts RE (2015a). Sex differences in the role of NADPH48
oxidases in endothelium-dependent vasorelaxation in porcine isolated coronary arteries.49
Vascul Pharmacol 72: 83-92.50
19
1
Wong PS, Roberts RE, & Randall MD (2014). Sex differences in endothelial function in2
porcine coronary arteries: a role for H2O2 and gap junctions? Br J Pharmacol 171: 2751-3
2766.4
5
Wong PS, Roberts RE, & Randall MD (2015b). Sex differences in the role of transient6
receptor potential (TRP) channels in endothelium-dependent vasorelaxation in porcine7
isolated coronary arteries. Eur J Pharmacol 750: 108-117.8
9
Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. (2003). Cloning of10
adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769.11
12
Yamawaki H, Tsubaki N, Mukohda M, Okada M, & Hara Y (2010). Omentin, a novel13
adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun14
393: 668-672.15
16
Yudkin JS, Eringa E, & Stehouwer CD (2005). "Vasocrine" signalling from perivascular fat:17
a mechanism linking insulin resistance to vascular disease. Lancet 365: 1817-1820.18
19
20
21
22
23
24
20
Figure 1: Effect of PVAT on U46619 and ET-1 -induced Arterial Contraction. Log1
concentration-response curves for the vasoconstrictor effects of U46619 (A & B) or ET-1 (C2
& D) in the absence (Control) or presence of PVAT (PVAT) in coronary arteries from female3
(A & C) and male pigs (B & D). Data are expressed as a percentage of the contraction to 604
mM KCl and are mean ± S.E.M. of 12(A), 6(B), 8(C), 7(D) experiments. * indicates p<0.05,5
2-tailed, paired Student’s t-test.6
7
Figure 2: PVAT-induced vasorelaxation in both sexes. Effects of PVAT (0.3 g) in female8
(A) and male (B) PCAs. Original trace of recording showing the response of female PCA to9
addition of PVAT (C). Effects of addition of PVAT (0.3 g) from female animals on coronary10
arteries from male animals (D). Data are expressed as a percentage relaxation from the11
U46619-induced tone and are expressed as mean ± S.E.M. of 8(A)-8(B)-6(C) experiments, *12
indicates p<0.05, 2-tailed, paired Student’s t-test.13
14
Figure 3: Role of NOS and COX in PVAT-induced vasorelaxation. (A) Log15
concentration-response curves for the vasoconstrictor effects of U46619 in the absence or16
presence of PVAT in female PCAs with and without pre-incubation with L-NAME (300 µM)17
and indomethacin (10 µM). Data are expressed as a percentage of the contraction to 60 mM18
KCl and are mean ± S.E.M. of 11 experiments. (B) Maximum response to the vasoconstrictor19
effects of U46619 in female PCAs with fat attached and either absence or presence of pre-20
incubation with L-NAME (300 µM) and indomethacin (10 µM). Data are expressed as a21
percentage of the contraction to 60 mM KCl and are mean ± S.E.M. of 6 experiments. *22
indicates p<0.05, one-way ANOVA v control followed by a Sidak’s post hoc test v control.23
24
Figure 4: Role of adiponectin in PVAT-induced vasorelaxtion. Effect of pre-incubation25
with an anti-adiponectin antibody on PVAT (0.3 g) –induced vasorelaxation in female PCAs.26
Data are expressed as a percentage change from the U46619-induced tone and are mean ±27
S.E.M. of 4 experiments. * indicates p<0.05, 2-tailed, Student’s paired t-test.28
29
30
21
Figure 5: Expression and release of adiponectin from PVAT. (A) Expression of1
adiponectin (30 kDa) and β-actin (42 kDa) levels in 20 µg of PVAT from female (F1-F6) and 2 
male (M1-M5) pigs. (B) Bar chart showing density of adiponectin bands normalised to b-3
actin levels, in PVAT from female and male animals. Data are expressed as mean ± SEM.4
(C) Comparison of the levels of adiponectin in the buffer after incubation with PVAT from5
female or male pigs for 1 hours. Data are expressed as a ratio of adiponectin released to6
whole weight of PVAT (0.15 g) and are mean ± S.E.M. of 6 female and 6 male PVAT7
samples.8
9
Figure 6: AdipoRon-induced arterial relaxation. Log concentration-response curves to10
adipoRon in coronary arteries from female and male pigs. Data are expressed as a percentage11
change from U46619-induced tone and are mean ± S.E.M. of 6 female and 8 male12
experiments. * indicates p<0.05, (2-way ANOVA followed by a Sidak’s post-hoc test).13
14
Figure 7: Expression of adiponectin receptors and adiponectin binding protein. (A)15
Expression of adipo 1 receptor (40 kDa) and β-actin (42 kDa) levels in 20 µg of PCA from 16 
female (F1-F6) and male (M1-M5) pigs. Porcine skeletal muscle is used as a positive control.17
(B) Expression of adipo 2 receptor (42 kDa) and myosin light chain (MLC) (20 kDa) levels in18
20 µg of PCA from female (F1-F5) and male (M1-M4) pigs. Rat liver is used as a positive19
control. (C) Bar chart showing density of adipo 2 receptor band normalised to MLC levels, in20
PCA from female and male animals. Data are expressed as mean ± SEM. (D) Expression of21
APPL1 (82 kDa) and β-actin (42 kDa) levels in 20 µg of PCA from female (F1-F5) and male 22 
(M1-M5) pigs. (E) Bar chart showing density of APPL1 band normalised to β-actin levels, in 23 
PCA from female and male animals. Data are expressed as mean ± SEM.24
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Supplementary Figure 1:1
2
Figure 1: Role of the endothelium in adipoRon-induced arterial relaxation. Log3
concentration-response curves to adipoRon in intact (control) or endothelium denuded4
coronary arteries from female and male pigs. Data are expressed as a percentage change from5
U46619-induced tone and are mean ± S.E.M. of 8 experiments.6
7
